Microvascular Po2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber

Pedro Cabrales, Nirmala Devi Kanika, Belur N. Manjula, Amy G. Tsai, Seetharama A. Acharya, Marcos Intaglietta

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The oxygen transport capacity of nonhypertensive polyethylene glycol (PEG)-conjugated hemoglobin solutions were investigated in the hamster chamber window model. Microvascular measurements were made to determine oxygen delivery in conditions of extreme hemodilution [hematocrit (Hct) 11%]. Two isovolemic hemodilution steps were performed with a 6% Dextran 70 (70-kDa molecular mass) plasma expander until Hct was 35% of control. Isovolemic blood volume exchange was continued using two surface-modified PEGylated hemoglobins (P5K2, P 50 = 8.6, and P10K2, P50 = 8.3; P50 is the hemoglobin PO2 corresponding to its 50% oxygen saturation) until Hct was 11%. P5K2 and P10K2 are PEG-conjugated hemoglobins that maintain most of the hemoglobin allosteric properties and have a cooperativity index of n = 2.2. The effects of these molecular solutions were compared with those obtained in a previous study using MP4, a PEG-modified hemoglobin whose P50 was 5.4 and cooperativity was 1.2 (Tsai et al., Am J Physiol Heart Circ Physiol 285: H1411-H1419, 2003). Tissue oxygen levels were higher after P5K2 (7.0 ± 2.5 mmHg) and P10K2 (6.3 ± 2.3 mmHg) versus MP4 (1.7 ± 0.5 mmHg) or the nonoxygen carrier Dextran 70 (1.3 ± 1.2 mmHg). Microvascular oxygen delivery was higher after P5K2 and P10K2 (2.22 and 2.34 ml O 2/dl blood) compared with MP4 (1.41 ml O2/dl blood) or Dextran 70 (0.90 ml O2/dl blood); however, all these values were lower than control (7.42 ml O2/dl blood). The total hemoglobin in blood was similar in all cases; therefore, the improvement in tissue PO 2 and oxygen delivery appears to be due to the increased cooperativity of the new molecules.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume287
Issue number4 56-4
DOIs
StatePublished - Oct 2004

Fingerprint

Hemodilution
Cricetinae
Hemoglobins
Oxygen
Dextrans
Hematocrit
Blood Volume

Keywords

  • Blood substitutes
  • Functional capillary density
  • Hemoglobin cooperativity
  • Oxygen-carrying capacity
  • Surface-modified hemoglobin
  • Tissue oxygen delivery

ASJC Scopus subject areas

  • Physiology

Cite this

Microvascular Po2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber. / Cabrales, Pedro; Kanika, Nirmala Devi; Manjula, Belur N.; Tsai, Amy G.; Acharya, Seetharama A.; Intaglietta, Marcos.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 287, No. 4 56-4, 10.2004.

Research output: Contribution to journalArticle

Cabrales, Pedro ; Kanika, Nirmala Devi ; Manjula, Belur N. ; Tsai, Amy G. ; Acharya, Seetharama A. ; Intaglietta, Marcos. / Microvascular Po2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber. In: American Journal of Physiology - Heart and Circulatory Physiology. 2004 ; Vol. 287, No. 4 56-4.
@article{d760d717d2784b6cb9f9b490921be6af,
title = "Microvascular Po2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber",
abstract = "The oxygen transport capacity of nonhypertensive polyethylene glycol (PEG)-conjugated hemoglobin solutions were investigated in the hamster chamber window model. Microvascular measurements were made to determine oxygen delivery in conditions of extreme hemodilution [hematocrit (Hct) 11{\%}]. Two isovolemic hemodilution steps were performed with a 6{\%} Dextran 70 (70-kDa molecular mass) plasma expander until Hct was 35{\%} of control. Isovolemic blood volume exchange was continued using two surface-modified PEGylated hemoglobins (P5K2, P 50 = 8.6, and P10K2, P50 = 8.3; P50 is the hemoglobin PO2 corresponding to its 50{\%} oxygen saturation) until Hct was 11{\%}. P5K2 and P10K2 are PEG-conjugated hemoglobins that maintain most of the hemoglobin allosteric properties and have a cooperativity index of n = 2.2. The effects of these molecular solutions were compared with those obtained in a previous study using MP4, a PEG-modified hemoglobin whose P50 was 5.4 and cooperativity was 1.2 (Tsai et al., Am J Physiol Heart Circ Physiol 285: H1411-H1419, 2003). Tissue oxygen levels were higher after P5K2 (7.0 ± 2.5 mmHg) and P10K2 (6.3 ± 2.3 mmHg) versus MP4 (1.7 ± 0.5 mmHg) or the nonoxygen carrier Dextran 70 (1.3 ± 1.2 mmHg). Microvascular oxygen delivery was higher after P5K2 and P10K2 (2.22 and 2.34 ml O 2/dl blood) compared with MP4 (1.41 ml O2/dl blood) or Dextran 70 (0.90 ml O2/dl blood); however, all these values were lower than control (7.42 ml O2/dl blood). The total hemoglobin in blood was similar in all cases; therefore, the improvement in tissue PO 2 and oxygen delivery appears to be due to the increased cooperativity of the new molecules.",
keywords = "Blood substitutes, Functional capillary density, Hemoglobin cooperativity, Oxygen-carrying capacity, Surface-modified hemoglobin, Tissue oxygen delivery",
author = "Pedro Cabrales and Kanika, {Nirmala Devi} and Manjula, {Belur N.} and Tsai, {Amy G.} and Acharya, {Seetharama A.} and Marcos Intaglietta",
year = "2004",
month = "10",
doi = "10.1152/ajpheart.00146.2004",
language = "English (US)",
volume = "287",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4 56-4",

}

TY - JOUR

T1 - Microvascular Po2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamber

AU - Cabrales, Pedro

AU - Kanika, Nirmala Devi

AU - Manjula, Belur N.

AU - Tsai, Amy G.

AU - Acharya, Seetharama A.

AU - Intaglietta, Marcos

PY - 2004/10

Y1 - 2004/10

N2 - The oxygen transport capacity of nonhypertensive polyethylene glycol (PEG)-conjugated hemoglobin solutions were investigated in the hamster chamber window model. Microvascular measurements were made to determine oxygen delivery in conditions of extreme hemodilution [hematocrit (Hct) 11%]. Two isovolemic hemodilution steps were performed with a 6% Dextran 70 (70-kDa molecular mass) plasma expander until Hct was 35% of control. Isovolemic blood volume exchange was continued using two surface-modified PEGylated hemoglobins (P5K2, P 50 = 8.6, and P10K2, P50 = 8.3; P50 is the hemoglobin PO2 corresponding to its 50% oxygen saturation) until Hct was 11%. P5K2 and P10K2 are PEG-conjugated hemoglobins that maintain most of the hemoglobin allosteric properties and have a cooperativity index of n = 2.2. The effects of these molecular solutions were compared with those obtained in a previous study using MP4, a PEG-modified hemoglobin whose P50 was 5.4 and cooperativity was 1.2 (Tsai et al., Am J Physiol Heart Circ Physiol 285: H1411-H1419, 2003). Tissue oxygen levels were higher after P5K2 (7.0 ± 2.5 mmHg) and P10K2 (6.3 ± 2.3 mmHg) versus MP4 (1.7 ± 0.5 mmHg) or the nonoxygen carrier Dextran 70 (1.3 ± 1.2 mmHg). Microvascular oxygen delivery was higher after P5K2 and P10K2 (2.22 and 2.34 ml O 2/dl blood) compared with MP4 (1.41 ml O2/dl blood) or Dextran 70 (0.90 ml O2/dl blood); however, all these values were lower than control (7.42 ml O2/dl blood). The total hemoglobin in blood was similar in all cases; therefore, the improvement in tissue PO 2 and oxygen delivery appears to be due to the increased cooperativity of the new molecules.

AB - The oxygen transport capacity of nonhypertensive polyethylene glycol (PEG)-conjugated hemoglobin solutions were investigated in the hamster chamber window model. Microvascular measurements were made to determine oxygen delivery in conditions of extreme hemodilution [hematocrit (Hct) 11%]. Two isovolemic hemodilution steps were performed with a 6% Dextran 70 (70-kDa molecular mass) plasma expander until Hct was 35% of control. Isovolemic blood volume exchange was continued using two surface-modified PEGylated hemoglobins (P5K2, P 50 = 8.6, and P10K2, P50 = 8.3; P50 is the hemoglobin PO2 corresponding to its 50% oxygen saturation) until Hct was 11%. P5K2 and P10K2 are PEG-conjugated hemoglobins that maintain most of the hemoglobin allosteric properties and have a cooperativity index of n = 2.2. The effects of these molecular solutions were compared with those obtained in a previous study using MP4, a PEG-modified hemoglobin whose P50 was 5.4 and cooperativity was 1.2 (Tsai et al., Am J Physiol Heart Circ Physiol 285: H1411-H1419, 2003). Tissue oxygen levels were higher after P5K2 (7.0 ± 2.5 mmHg) and P10K2 (6.3 ± 2.3 mmHg) versus MP4 (1.7 ± 0.5 mmHg) or the nonoxygen carrier Dextran 70 (1.3 ± 1.2 mmHg). Microvascular oxygen delivery was higher after P5K2 and P10K2 (2.22 and 2.34 ml O 2/dl blood) compared with MP4 (1.41 ml O2/dl blood) or Dextran 70 (0.90 ml O2/dl blood); however, all these values were lower than control (7.42 ml O2/dl blood). The total hemoglobin in blood was similar in all cases; therefore, the improvement in tissue PO 2 and oxygen delivery appears to be due to the increased cooperativity of the new molecules.

KW - Blood substitutes

KW - Functional capillary density

KW - Hemoglobin cooperativity

KW - Oxygen-carrying capacity

KW - Surface-modified hemoglobin

KW - Tissue oxygen delivery

UR - http://www.scopus.com/inward/record.url?scp=7444231150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444231150&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00146.2004

DO - 10.1152/ajpheart.00146.2004

M3 - Article

VL - 287

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4 56-4

ER -